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chromosome in a child with leukocyte
adhesion deficiency
To the Editor:
Leukocyte adhesion deficiency type 1 (LAD-1, MIM:116920)
is a rare, autosomal-recessive primary immunodeficiency disorder
caused by defects in ITGB2, a gene mapping on chromosome
21q22.31-3 and encoding for the b2-integrins subunit, CD18.4,5
LAD-1 is characterized by extreme elevation of blood neutrophil
counts, recurrent fungal and bacterial infections, slow wound
healing, and dystrophic scars from skin injuries. The severity of
symptoms is correlated with the level of CD11/CD18 expression.
Generally, patients with less than 1% expression of CD11/CD18are susceptible to frequent and life-threatening systemic infec-
tions and require hematopoietic stem cell transplantation (HSCT).
Ring 21 (r[21]), is a rare chromosomal abnormality6 whose
classic phenotype includes hypertonia, prominent nasal bridge,
downward slanting palpebral fissures, protuberant occiput, and
large ears. Microcephaly, sparse curly hair, prominent forehead,
long eye lashes, broad anteverted nasal tip, long philtrum, thin up-
per lip, small mouth, and retrognathia are also commonly seen.7,8
Other manifestations include the consistent features of prenatal
and postnatal growth retardation, hematologic disorder, a distinc-
tive facies, and cognitive impairment.
We report on a child with LAD-1, dysmorphic features, and
growth retardation caused by a combination of a point mutation in
ITGB2 and a gross deletion resulting in r(21).
The patient is the only child of nonconsanguineous parents.
Delivered at 36 weeks after labor induction for suspected intra-
uterine growth retardation, his birth weight was 1785 g (<3rd
percentile), length 42 cm (<3rd percentile) and head circumfer-
ence 30 cm (<3rd percentile). Perinatality was characterized by
delayed umbilical cord separation. During workup for herniot-
omy, a subvalvular aortic stenosis was discovered, and postoper-
atively slow wound healing was noted. Because of persistent
anemia and leukocytosis (52 3 109/L), he was referred to ourFIG 1. Chromatograms of portion of ITGB2 gene sequence in the proband and his parents. The c.79A > T
mutation is marked by an arrow. Note that for the mutated position, the father, the mother, and the affected
son showed the AA, AT, and TT genotypes, respectively.
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admission, microcephaly, prominent forehead, flat nasal bridge,
downward slanting palpebral fissures, and large ears were noted.
He had sparse, thin hair, long eye lashes, broad anteverted nasal
tip, long philtrum, a small mouth with thin lips, and micrognathia.
A holosystolic murmur (4/6) was audible, and the hypoplastic
scrotum harbored only the right testicle (volume 1 mL). Swabs
from the umbilicus and the surgical wound grew E faecalis and
C parapsilosis. Immunologic workup revealed normal lympho-
cyte subpopulations with good proliferative response tomitogens,
normal IgG and IgM, and low IgA serum levels. Lack of CD11b
and CD18 expression on the surface of polymorphonuclear leuko-
cytes and lymphocytes prompted a diagnosis of LAD-1.
The boy was isolated in a laminar air flow regimen, and HSCT
was performed at 7 months of age from a matched unrelateddonor. At 2 years after HSCT, >99% of the patients’ neutrophils
and lymphocytes expressed normal levels of CD18. The patient is
currently awaiting cardiac surgery to correct the subvalvular
aortic stenosis.
Sequencing of the ITGB2 cDNA of the patient revealed a ho-
mozygous nonsense mutation in exon 3 (NM_000211.3: c.79A
> T; NP_000202.2: p.Lys27X). The same mutation was detected
in heterozygosis in the mother, but not in the father (Fig 1). Once
paternity was confirmed, the presence of a gross deletion span-
ning the entire ITGB2 gene on the paternally derived allele was
hypothesized.
Cytogenetic analysis on fibroblasts from a skin biopsy and
performed using QFQ banding with 450 band resolution
revealed the presence of 1 normal chromosome 21 and a ring of
the second 21 (Fig 2, A).FIG 2. Cytogenetic and single nucleotide polymorphism array analyses. A, Patient’s Q-banding (arrow). B,
FISH painting of chromosome 21 shows signal on 2 chromosomes, including the ring chromosome (arrow).
C, FISH using BAC clone RP11-15F6 reveals lack of signal on 1 of the 2 chromosomes 21 (arrow). D, Copy
number state of chromosome 21 probes inferred by CNAG and reported as logarithm to the base 2 of the
intensity ratio between proband and controls set. The arrow points to the deleted region.
Placental transfer of allergen-specific IgG
but not IgE from a specific immunotherapy–
treated mother
To the Editor:
Several reports suggest that allergic sensitization can be
influenced already in utero.1 Some studies indicate that allergic
sensitization can occur in utero by transfer of allergens via the
placenta to the child,2,3 whereas others have argued against this
possibility and suggest that allergen-specific IgE in cord blood
does not reflect intrauterine sensitization but rather is the result
of a transfer of maternal IgE to the fetus.4 However, whether
IgE and in particular allergen-specific IgE can be transferred
via the placenta to the child represents a controversial issue.
The presence of allergen-specific IgE antibodies in children
with specificities similar to those of their mothers has been re-
ported in 2 studies,4,5 whereas others suggested that the placenta
represents a barrier for IgE antibodies.6,7
We had the opportunity to study the antibody reactivity profiles
in serum samples from amother with birch and grass pollen allergy
(IgE levels before specific immunotherapy: 18.50 kilo units [kU]/L
total IgE, 1.8 kUA/L recombinant [r] Bet v 1, 2.48 kUA/L rPhl p
1 1 rPhl p 5) who had received subcutaneous injection immuno-
therapy with birch and grass pollen extracts (Alutard SQ; ALK-
Abello´, Hørsholm, Denmark) for 2 years before she became
pregnant and delivered her baby as well as in the corresponding
cord blood sample of her child using an array of purified allergen
molecules. To the best of our knowledge, this is the first detailed
analysis of allergen-specific IgE (Fig 1), IgG1, and IgG4 antibodies
(Fig 2) to purified allergen molecules from several different
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(WCP) of chromosome 21 confirmed that the ring was derived
from chromosome 21, whereas FISH performed by using a 21q-
specific telomere probe and BAC clone RP11-15F6, containing
the ITGB2 sequence, showed a complete lack of signals on the
r(21) chromosome (Fig 2,B and C). On the basis of these findings,
we determined the karyotype to be 46, XY, ish r(21) (WCP1,
21qtel-, RP11-15F6-).9
Conventional chromosomal and FISH analysis with the same
probes revealed normal results in both parents.
The Whole Genome Analysis of the trio with the Affymetrix
GeneChip Human Mapping 250 K NspI array (Affymetrix, Santa
Clara, Calif) confirmed the presence in the proband of a heterozy-
gous de novo deletion in the chromosome region 21q22.3-qter
(Fig 2, D). According to CNAT4 software (Affymetrix), the dele-
tion breakpoint mapped between SNP_A-2020087 (42,346,671
bp) and SNP_A-4209155 (42,365,654 bp), whereas, according
to CNAG software (Affymetrix), the breakpoint was included
between 42,374,607 bp and 42,389,446 bp. The deletion spanned
4.6 Mb and, besides the ITGB2 gene, included 69 additional
genes, among which were the ADARB1 gene encoding for the en-
zyme responsible for pre-mRNA editing of the glutamate receptor
subunit B, and COL18A, COL6A, and COL6A2 genes encoding
for members of the collagen superfamily.
These results confirm that most often different pathologies
occurring in the same person can be related to 1 common cause,
and emphasize the importance of including cytogenetic analysis
in patients with complex clinical phenotypes.
The boy we have reported, besides the typical features of r(21),
also had the characteristic findings of LAD-1. Typically, the loss
of 1 allele of ITGB2 does not lead to a clinical immunodeficiency
because this disease is inherited as an autosomal-recessive trait;
however, in our patient, the LAD-1 phenotype was disclosed by
an ITGB2 nonsense mutation that he inherited from the heterozy-
gous mother. CD18 is expressed on blood leukocytes, and hence,
donor stem cell engraftment leads to correction of the LAD-1 phe-
notype. Although LAD-1 can be cured by HSCT, this is not the
case for the other r(21)-associated clinical features. Indeed, at
18 months of age, although he has no evidence of immune defi-
ciency, he remains beneath the third percentile for height, weight,
and cranial circumference, and also shows signs of neurodevelop-
mental delay.
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